文献标引:初乃惠，黄学锐.氟喹诺酮类药物在结核病治疗中的应用[J/CD].中华临床医师杂志：电子版,2010,4(7):905-907.

参考文献:
[1]　马玙，黄学锐.喹诺酮类药物的抗结核作用.中国医院用药评价与分析，2004,4(5)：305-306.
[2]　章怡彬，刘明亮，郭慧元.氟喹诺酮：一类重要的抗结核药物.国外医药：抗生素分册，2009,30(1)：19-24.
[3]　Cole ST，Brosch R，Parkhill J，et al.Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.Nature,1998,393(6685)：537-544.[PubMed]
[4]　Hu Y， Coates AR， Mitchison DA. Sterilizing activities of fluoroquinolonesagainst rifampin-tolerant populations of Mycobacterium tuberculosis.Antimicrob Agents Chemother,2003,47(2)：653-657.[PubMed]
[5]　WHO. Guidelines for the programmztic management of drug-resistant tuberculosis.WHO/HTM/TB/2008.402. Geneva：WHO,2008.
[6]　Yew WW， Chan CK， Leung CC， et al. Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis：preliminary results of a retrospective study from Hong Kong.Chest,2003,124(4)：1476-1481.[PubMed]
[7]　Mangunnegoro H，Hudoyo A.Efficacy of low-dose ofloxacin in the treatment of multidrug-resistant tuberculosis in Indonesia.Chemotherapy,1999,45 Suppl 2：19-25.[PubMed]
[8]　Maranetra KN.Quinolones and multidrug-resistant tuberculosis.Chemotherapy,1999,45 Suppl 2：12-18.[PubMed]
[9]　Yew WW，Kwan SY，Ma WK，et al.In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multidrug resistant pulmonary tuberculosis.J Antimicrob Chemother,1990,26(2)：227-236.[PubMed]
[10]　黄学锐，高微微，卜建玲，等.69例耐多药肺结核个体化治疗的疗效分析.中国防痨杂志，2004,26(5)：257-260.
[11]　Alangaden GJ， Manavathu EK， Vakulenko SB，et al. Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients. Antimicrob Agents Chemother,1995,39(8)：1700-1703.[PubMed]